On this site you will find clinical studies with cannabis or single
cannabinoids in different diseases and case reports on the use of cannabis by
You may search for diseases (indications), authors, medication, study design (controlled study, open trial, case report etc.) and other criteria.
|Title||[Topical cannabinoid agonists : An effective new possibility for treating chronic pruritus.] [Article in German]|
|Author(s)||Stander S, Reinhardt HW, Luger TA.|
|Journal, Volume, Issue||Hautarzt. 2006 Sep;57(9):801-7.|
|Major outcome(s)||Topical application of a cream with N-palmitoyl ethanolamine had a good antipruritic effect in most patients.|
BACKGROUND: Chronic, therapy-resistant pruritus often fails to respond to standard measures so new therapeutic approaches are needed. Recently, the expression of cannabinoid receptors on cutaneous sensory nerve fibers was described, so cannabinoid agonists seem a rational therapeutic option for pruritus.PATIENTS: In an open application observation 22 patients with prurigo, lichen simplex and pruritus applied an emollient cream containing N-palmitoyl ethanolamine (PEA).RESULTS: In 14/22 patients a good antipruritic effect could be documented. The average reduction in itch was 86.4%. The therapy was well-tolerated by all patients; neither burning burn nor contact dermatitis was observed.CONCLUSIONS: Topical cannabinoid agonists represent an new effective and well-tolerated therapy for refractory itching of various origins. Creams with a higher concentration may be even more effective with broader indications.
|Participants||22 patients with pruritus|
|Type of publication||Medical journal|
|Address of author(s)||Abteilung fur Klinische Neurodermatologie, Klinik und Poliklinik fur Hautkrankheiten, Universitatsklinikum Munster, Von-Esmarchstrasse 58, 48149 , Munster, email@example.com.|